Several Hong Kong-listed innovative drug ETFs rose more than 1%.

In the morning session, the pharmaceutical sector of Hong Kong stocks continued to rise, with several innovative drug ETFs up more than 1%. As of the time of writing, WanJia CSI Hong Kong Stock Connect Innovative Medicine ETF rose by 1.99%, Huatai Bairui Hang Seng Innovative Medicine ETF rose by 1.81%, Huitongfu Guoji Hong Kong Stock Connect Innovative Medicine ETF rose by 1.74%, and Invesco Great Wall CSI Hong Kong Stock Connect Innovative Medicine ETF rose by 1.75%.